ASX Penny Stocks Spotlight: Immutep And Two More To Consider

The Australian stock market recently experienced a solid performance, buoyed by higher gold and silver prices and a positive ...

ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lun…

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
The American Journal of Managed Care

Systemic Inflammation Linked to Disease Severity, Treatment Response in Alopecia Areata

Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...
Medscape

The Gut’s Unexpected Role in Sepsis-Induced Liver Damage

Researchers have examined cellular crosstalk between the gut and liver during sepsis, helping us better understand sepsis ...
Science Daily

This new antibody may stop one of the deadliest breast cancers

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
GlobalData on MSN

ImmunityBio’s Anktiva shows success as combo treatment in NSCLC

Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...
Targeted Oncology

Nogapendekin Alfa Inbakicept Shows Promise in Checkpoint-Refractory NSCLC

QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, ...

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Data from eight participants continue to support safety and tolerability profile of tegoprubartMean eGFR increased over the measurement period, ...
News-Medical.Net on MSN

Study reveals innate immune barriers to long-term pig kidney transplant survival

Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to receive a genetically modified pig kidney transplant. This paves the way for the ...

The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
Study Finds on MSN

What If Your Skin Could Warn You About Disease Before Symptoms Appear By Glowing Green?

Green means go…to the doctor In A Nutshell Scientists engineered living skin that glows green when it detects inflammation in ...

Could a Simple Nasal Drop Treat the Deadliest Brain Cancer?

A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...